Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in Situ squamous cell carcinoma of the uterine cervix

Clinical Cancer Research

Volumn 6, Issue 9, 2000, Pages 3600-3606

  Giarnieri, E ^a   Mancini, R ^a   Pisani, T ^a   Alderisio, M ^a   Vecchione, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN FHIT; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ACID ANHYDRIDE HYDROLASES; ADULT; AGED; BASE PAIR MISMATCH; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN BIOSYNTHESIS; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 0033812996     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Epidemiology of cervical cancer. Overview
2. The Revised Bethesda System for reporting cervical/vaginal cytological diagnoses: Report of the 1991 Bethesda workshop
3. Molecular characterization of adenocarcinoma of the cervix
4. The Bethesda system and evaluation of abnormal pap smears
5. Human papillomavirus type 18 and intraepithelial lesions of the cervix
6. Mutations of p53 and human papillomavirus infection in cervical carcinoma
7. Progression and regression of cervical lesions: Review of smears from women followed without initial biopsy or treatment
8. The role of human papillomaviruses in the pathogenesis and histologic classification of precancerous lesions of the cervix
9. Clues to the pathogenesis of familial colorectal cancer
10. The human mutator gene homologue MSH2 and its association with hereditary nonpolyposis colon cancer
11. Hypermutability and mismatch repair deficiency in RER + tumor cells
12. Mutations of a mutS homologue in hereditary nonpolyposis colorectal cancer
13. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers
14. The FHIT gene at 3p14.2 is abnormal in breast carcinomas
15. Tumor suppressor p53 is a regulator of bcl-2 and box gene expression in vitro and in vivo
16. Wild type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
17. Apoptosis: Gene-directed cell death. An Overview
18. Apoptosis: Its significance in cancer and cancer therapy
19. Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma
20. Bcl-2 and regulation of programmed cell death
21. Bad, a heterodimeric partner for bcl-X(L) and bcl-2, displaces bax and promotes cell death
22. Bcl-2 heterodimerizes in vivo with a conserved homologue, BAX, that accelerates programmed cell death
23. Bcl-2 protein expression and long term survival in breast cancer
24. Landscaping the cancer terrain
25. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis
26. Tumors of DNA mismatch repair deficient hosts exhibit dramatic increases in genomic instability
27. Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissue
28. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes
29. Microsatellite instability in cervical and endometrial carcinomas
30. Genomic deletion and p53 inactivation in cervical carcinoma
31. +) phenotypes in cervical carcinoma
32. Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: A local field effect of genomic instability and clonal evolution
33. Genetic alterations at 5p15: A potential marker for progression of precancerous lesions of the uterine cervix
34. The FHIT gene at 3p14.2 is abnormal in lung cancer
35. Structure and expression of the human FHIT gene in normal and tumor cells
36. FHIT gene alterations in head and neck squamous cell carcinomas
37. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors
38. Role of FHIT in human cancer
39. Abnormalities of fragile histidine triad genomic and complementary DNA in cervical cancer: Association with human papilloma virus type
40. Loss of FHIT expression in gastric carcinoma
41. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma
42. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix
43. A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix
44. FHIT gene expression in human ovarian, endometrial, and cervical cell lines
45. Abnormal Fhit expression in malignant and premalignant lesion of the cervix
46. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control
47. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
48. Prognostic significance of Bcl-2 and p53 protein expression in stage IIb and IIIb squamous cell carcinoma of the cervix
49. Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer
50. An immunohistochemical study of p53 protein in cervical intraepithelial neoplasia and squamous cell carcinoma
51. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas
52. p53 Expression in breast cancer
53. Detection of p53 in primary lung tumors and non-small cell lung carcinoma cell lines
54. Energy requirement for degradation of tumor-associated protein p53
55. Activating mutations for transformation by p53 produce a gene product that forms an hsc 70-p53 with an altered half-life
56. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18
57. Multiple bcl-2 family members demonstrate selective dimerisation with bax
58. Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix
59. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix